Questions About PPSV23 Effectiveness for Community-Acquired Pneumonia
How effective is the 23-valent pneumococcal polysaccharide vaccine (PPSV23) for the prevention of serotype-specific, community-acquired pneumonia? Thanks to new technology, a study has come up with the answer to that question. Concerns exist about the effectiveness of the PPSV23 in preventing some types of community-acquired pneumonia. Using new techniques, researchers were able to quantify how little protection is actually offered. Read more.
|
|